MEDI-1814 is a fully human IgG1 antibody targeting the C-terminus of Abeta42. It binds to and eliminates circulating Abeta peptides, thereby preventing their aggregation into toxic oligomers. MEDI-1814 is applicable in Alzheimers disease research. For an isotype control, refer to HumanIgG1kappa, Isotype Control.
Target-Kategorie:
Beta Amyloid
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
